Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 4
2002 23
2003 27
2004 31
2005 26
2006 54
2007 46
2008 60
2009 64
2010 54
2011 62
2012 54
2013 42
2014 35
2015 30
2016 36
2017 29
2018 24
2019 34
2020 34
2021 25
2022 28
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

754 results
Results by year
Filters applied: . Clear all
Page 1
Travoprost/timolol.
Hoy SM, Keam SJ, Keating GM. Hoy SM, et al. Drugs Aging. 2006;23(7):587-97; discussion 598-9. doi: 10.2165/00002512-200623070-00005. Drugs Aging. 2006. PMID: 16930087 Review.
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F(2alpha) analogue travoprost and the beta-adrenoceptor antagonist timolol. ...Travoprost/timolol was generally well to
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostag
Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis.
Tang W, Zhang F, Liu K, Duan X. Tang W, et al. Medicine (Baltimore). 2019 Jul;98(30):e16597. doi: 10.1097/MD.0000000000016597. Medicine (Baltimore). 2019. PMID: 31348303 Free PMC article.
The difference of intraocular pressure (IOP) reduction between latanoprost and travoprost group had not significant; there was significant difference of IOP reduction between latanoprost and bimatoprost group in the third month and sixth month; Travoprost was signif …
The difference of intraocular pressure (IOP) reduction between latanoprost and travoprost group had not significant; there was signif …
Travoprost.
Waugh J, Jarvis B. Waugh J, et al. Drugs Aging. 2002;19(6):465-71; discussion 472-3. doi: 10.2165/00002512-200219060-00005. Drugs Aging. 2002. PMID: 12149052 Review.
Travoprost is a synthetic ester prodrug of a prostaglandin F(2alpha) analogue used in the treatment of open-angle glaucoma and ocular hypertension. ...Travoprost 0.004% was well tolerated in clinical trials. The majority of adverse events such as ocular hyperaemia a
Travoprost is a synthetic ester prodrug of a prostaglandin F(2alpha) analogue used in the treatment of open-angle glaucoma and ocular
Travoprost/timolol fixed combination.
Herceg M, Noecker R. Herceg M, et al. Expert Opin Pharmacother. 2008 Apr;9(6):1059-65. doi: 10.1517/14656566.9.6.1059. Expert Opin Pharmacother. 2008. PMID: 18377347 Review.
BACKGROUND: Travoprost and timolol are topical ocular hypotensive medications that have been used in the treatment of glaucoma. ...Studies selected for review compared efficacy and side-effect profile of fixed combination travoprost/timolol with travoprost an …
BACKGROUND: Travoprost and timolol are topical ocular hypotensive medications that have been used in the treatment of glaucoma. ...St …
Travoprost 0.004%/timolol 0.5% fixed combination.
Noecker RJ, Awadallah NS, Kahook MY. Noecker RJ, et al. Drugs Today (Barc). 2007 Feb;43(2):77-83. doi: 10.1358/dot.2007.43.2.1032058. Drugs Today (Barc). 2007. PMID: 17353945 Review.
Fixed-combination travoprost/timolol solution consists of travoprost 0.004% and timolol 0.5%. Several studies have demonstrated the efficacy and safety of this medication used once daily for the treatment of open-angle glaucoma and ocular hypertension. This fixed co …
Fixed-combination travoprost/timolol solution consists of travoprost 0.004% and timolol 0.5%. Several studies have demonstrate …
Travoprost--a new prostaglandin analogue for the treatment of glaucoma.
Whitson JT. Whitson JT. Expert Opin Pharmacother. 2002 Jul;3(7):965-77. doi: 10.1517/14656566.3.7.965. Expert Opin Pharmacother. 2002. PMID: 12083996 Review.
Travoprost is distinguished from other marketed prostaglandin analogues in that it is a full agonist at the prostaglandin receptor. ...Throughout all clinical trials, travoprost was found to be safe and well-tolerated with very few (< 5%) discontinuations due to
Travoprost is distinguished from other marketed prostaglandin analogues in that it is a full agonist at the prostaglandin receptor. .
Evaluation of Physical Properties of Generic and Branded Travoprost Formulations.
Wadhwani M, Mishra SK, Angmo D, Velpandian T, Sihota R, Kotnala A, Bhartiya S, Dada T. Wadhwani M, et al. J Curr Glaucoma Pract. 2016 May-Aug;10(2):49-55. doi: 10.5005/jp-journals-10008-1201. Epub 2016 Aug 5. J Curr Glaucoma Pract. 2016. PMID: 27536047 Free PMC article. Review.
PURPOSE: Comparative evaluation of pharmaceutical characteristics of three marketed generic vs branded travoprost formulations. MATERIALS AND METHODS: Three generic travoprost formulations and one branded (Travatan without benzalkonium chloride) formulation (10 vial …
PURPOSE: Comparative evaluation of pharmaceutical characteristics of three marketed generic vs branded travoprost formulations. MATER …
Travoprost: a potent ocular hypotensive agent.
Al-Jazzaf AM, DeSantis L, Netland PA. Al-Jazzaf AM, et al. Drugs Today (Barc). 2003 Jan;39(1):61-74. doi: 10.1358/dot.2003.39.1.799432. Drugs Today (Barc). 2003. PMID: 12669109 Review.
Like other compounds of this class, the reduction of intraocular pressure by travoprost is due at least in part to increased uveoscleral outflow. ...Travoprost is a safe drug, with local side effects including hyperemia, eyelash growth and iris color change. ...
Like other compounds of this class, the reduction of intraocular pressure by travoprost is due at least in part to increased uveoscle …
The prostaglandin wars.
Kaufman PL. Kaufman PL. Am J Ophthalmol. 2003 Oct;136(4):727-8. doi: 10.1016/s0002-9394(03)00658-5. Am J Ophthalmol. 2003. PMID: 14516814 No abstract available.
Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients.
Cai Z, Cao M, Liu K, Duan X. Cai Z, et al. J Ophthalmol. 2021 May 25;2021:5586719. doi: 10.1155/2021/5586719. eCollection 2021. J Ophthalmol. 2021. PMID: 34123413 Free PMC article. Review.
There was no significant difference in the IOP-reducing efficacy of travoprost, latanoprost, and tafluprost. In LNRs, the responsiveness of bimatoprost, travoprost, and latanoprost did not show statistical differences. Bimatoprost reduced IOP with a greater extent t …
There was no significant difference in the IOP-reducing efficacy of travoprost, latanoprost, and tafluprost. In LNRs, the responsiven …
754 results